Shares of ResMed Inc. RMD advanced 1.44% to $239.48 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.04% to 6,115.07 and ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research Report) received a Buy rating and price target from ...

Shares of ResMed Inc. RMD shed 2.23% to $237.18 Thursday, on what proved to be an all-around mixed trading session for the ...

In a report released on February 1, Steven Wheen from Jarden maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 ...

People who have trouble breathing as they sleep often turn to ResMed, which makes a face-worn breathing apparatus. Its ...

NYSE RMD opened at $236.66 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.92 and a quick ratio of 1.91. ResMed has a 12 month low of $170.56 and a 12 month high of ...

Shares of ResMed (RMD) have been struggling lately and have lost 7.1% over the past two weeks. However, a hammer chart ...

Needham & Company LLC restated a “hold” rating on shares of ResMed in a research note on Friday, January 31st. Robert W. Baird increased their target price on ResMed from $280.00 to $283.00 an ...

In future, our dividend and earnings forecasts will be shown on a USD per share basis. Each ResMed share is equivalent to 10 CDIs. The shares are traded in the US, whereas the CDIs are traded on ...

Key Insights Significantly high institutional ownership implies ResMed's stock price is sensitive to their trading ...